Will LYB disclose European divestiture proceeds of $500M or more when the transaction closes in Q2 2026?
Current Prediction
Why This Question Matters
Tests the liquidity and capital-discipline storyline. Stress Scanner's coverage math and Roadkill Radar's orderly-recovery path both assume $500-800M in European divestiture proceeds. Proceeds at or above $500M validate the orderly-simplification thesis and extend balance-sheet optionality through the trough. Proceeds below $500M or a failed transaction signal distressed pricing on unprofitable assets and tighten the coverage math for the dividend/capex/Saudi-JV triangle.
Prediction Distribution
Individual Predictions(9 runs)
Committee's $500-800M range is presented as the assumption, implying some signaling basis. $500M is the lower bound of the range. Given (a) assets are loss-making at trough (Q4 -$61M EBITDA), (b) trough-pricing dynamics, (c) working-capital/environmental adjustments typically reduce reported figures, the expected-value is likely near the midpoint ($650M) with wide dispersion. Probability P(proceeds ≥ $500M) assuming symmetric distribution around $650M with sigma ~$200M is ~0.77; adjust down for distressed-pricing risk and ambiguous disclosure. Settle 0.55.
Chemical asset sales at trough often produce below-range proceeds as buyers demand discount. Private equity appetite for European chemical assets has been limited through 2024-2025. Strategic buyer pool narrow (competitor consolidation limited). The $500M threshold is the LOW end of the committee's cited range. If the transaction comes in at $500-800M, this resolves YES; only if it slips below $500M (distress) or the transaction is restructured/delayed does it resolve NO. Moderate uncertainty on close-date disclosure timing. Settle 0.52.
Management has cited Q2 2026 close with confidence; binding agreement already in place. Committee flagged 'portfolio simplification on track' with operational execution credibility. The $500-800M range is specific enough to suggest management has internal visibility. Some risk of delay but low risk of outright termination. Probability of close AND proceeds ≥$500M ~55-60%. Settle 0.58.
$500M threshold sits at the low boundary of committee's range. If distribution of outcomes is roughly uniform across $500-800M with 20% left-tail below $500M, probability YES ~0.70. However, discounting for close-timing risk and disclosure ambiguity, 0.50-0.55.
Committee range is $500-800M which straddles the threshold. Base case P(proceeds >=$500M | close on schedule) ~0.75-0.80. Adjusted for timing risk (~15% slip to Q3) ~0.60-0.65. Further adjusted for reporting ambiguity 0.55.
Balance committee range support (favorable) against trough-pricing on loss-making assets (unfavorable) and disclosure/timing risks. Central 0.50.
Committee range $500-800M; binding agreement; $500M threshold likely met but with close-timing risk. 0.55.
Moderate confidence; 50-55% reflects uncertainty on pricing and reporting.
Base case around midpoint of range; threshold at low end gives YES bias. 0.55.
Resolution Criteria
Resolves YES if LYB discloses, in an 8-K, press release, or Q2 2026 10-Q (filed by 2026-08-15), closing-date transaction proceeds or consideration of $500M or more (gross cash received, before working-capital adjustments). Resolves NO if disclosed proceeds are below $500M, if the transaction is terminated, delayed beyond Q3 2026, or if LYB discloses that proceeds will not be separately quantified (e.g., wrapped in a larger portfolio transaction).
Resolution Source
LYB 8-K closing announcement, Q2 2026 earnings release, or Q2 2026 10-Q
Source Trigger
European divestiture Q2 2026 closing — proceeds $500-800M range underpins Stress Scanner liquidity and Roadkill Radar recovery path
Full multi-lens equity analysis